1. Home
  2. DRCT vs BJDX Comparison

DRCT vs BJDX Comparison

Compare DRCT & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$2.61

Market Cap

2.0M

Sector

Technology

ML Signal

HOLD

Logo Bluejay Diagnostics Inc.

BJDX

Bluejay Diagnostics Inc.

HOLD

Current Price

$1.06

Market Cap

1.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRCT
BJDX
Founded
2018
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0M
1.8M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DRCT
BJDX
Price
$2.61
$1.06
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$32.00
N/A
AVG Volume (30 Days)
15.0K
4.8M
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
86.65
EPS
N/A
N/A
Revenue
$34,694,000.00
$249,040.00
Revenue This Year
$5.42
N/A
Revenue Next Year
$9.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.63
52 Week High
$7.21
$7.00

Technical Indicators

Market Signals
Indicator
DRCT
BJDX
Relative Strength Index (RSI) 42.81 33.07
Support Level $2.51 $0.63
Resistance Level $3.02 $2.10
Average True Range (ATR) 0.14 0.18
MACD 0.01 0.02
Stochastic Oscillator 51.00 3.90

Price Performance

Historical Comparison
DRCT
BJDX

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

Share on Social Networks: